Results 111 to 120 of about 4,412 (151)

Assessment of the factors affecting the clinical outcomes of infection and safety of vaccines against SARS-CoV-2 among Egyptian patients

BMC Infectious Diseases
Background Understanding the factors that influence clinical outcomes of COVID-19 and the safety of various vaccines is important to inform public health strategies, particularly in diverse communities.
Amira A. Zidan, Ahmed Yousef Jad, Nermine H. Zakaria, Hazem M. El-Hariri, Maged El-Setouhy   +4 more
doaj   +1 more source

BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome. [PDF]

Vaccines (Basel), 2023
Shen Y, Dong Y, Jiao J, Wang P, Chen M, Li J.   +5 more
europepmc   +1 more source

Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine. [PDF]

Immun Inflamm Dis, 2022
Jeewandara C, Aberathna IS, Pushpakumara PD, Kamaladasa A, Guruge D, Wijesinghe A, Gunasekera B, Ramu ST, Kuruppu H, Ranasinghe T, Dayarathna S, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Jayathilaka D, Dissanayake M, Jayadas TT, Mudunkotuwa A, Somathilake G, Harvie M, Nimasha T, Danasekara S, Wijayamuni R, Schimanski L, Rijal P, Tan TK, Dong T, Townsend A, Ogg GS, Malavige GN.   +30 more
europepmc   +1 more source

Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV. [PDF]

Cureus, 2023
Wijekoon L, Sarathchandra C, Siribaddana S.   +2 more
europepmc   +1 more source

Safety of the BBIBP-CorV COVID-19 Vaccine in Relation to Adverse Clinical Outcomes in Newborns: A Prospective Cohort Study. [PDF]

Int J Womens Health
Muhetaier R, Zhang L, Ding G, Wang K, Li X.   +4 more
europepmc   +1 more source

Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine. [PDF]

Clin Infect Dis
Chissumba RM, Kwatra G, Ramgi P, Enosse M, Sigaúque A, Khosa C, Viegas E, Bule O, Langa J, Dhar N, Mukendi C, Langa D, Sevene E, Hermanus T, Manamela N, Richardson S, Moore P, Madhi S, Jani IV, SIVCOV study group .   +19 more
europepmc   +1 more source

Biochemical and histopathological evaluation of ChAdOx1-S and BBIBP-CorV vaccination in normal and streptozotocin-induced diabetic Wistar rats. [PDF]

PLoS One, 2023
Teymoorzadeh M, Daneshfar N, Yazdanparast R.   +2 more
europepmc   +1 more source

False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19. [PDF]

Front Med (Lausanne)
Moya-Salazar J, Ciprian LY, Rojas-Zumaran V, Moya-Salazar B, Goicochea-Palomino EA, Contreras-Pulache H.   +5 more
europepmc   +1 more source

Exploring Immune Responses to SARS-CoV-2: Insights from Sinopharm (BBIBP-CorV)-Vaccinated Individuals in a Group of Venezuelan Admixed Volunteers. [PDF]

Biomedicines
García AH, Mayora SJ, Medina C, Belisario IA, Martínez WY, Crespo FI, De Sanctis JB.   +6 more
europepmc   +1 more source

Immunogenicity and safety of the BBIBP-CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort. [PDF]

Immun Inflamm Dis, 2023
Zamani B, Moradi Hasan-Abad A, Piroozmand A, Dehghani M, Arfaatabar M, Motedayyen H.   +5 more
europepmc   +1 more source